## Abstract Even though __SQSTM1__ gene mutations have been identified in a consistent number of patients, the etiology of Paget's disease of bone (PDB) remains in part unknown. In this study we analyzed __SQSTM1__ mutations in 533 of 608 consecutive PDB patients from several regions, including the
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone
β Scribed by Micaela Rios Visconti; Anne L Langston; Nerea Alonso; Kirsteen Goodman; Peter L Selby; William D Fraser; Stuart H Ralston
- Publisher
- American Society for Bone and Mineral Research
- Year
- 2010
- Tongue
- English
- Weight
- 80 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0884-0431
- DOI
- 10.1002/jbmr.132
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Paget disease of bone (PDB) is a common disorder characterized by increased bone turnover at one of more sites throughout the skeleton. Genetic factors play an important role in the pathogenesis of PDB, and the most important predisposing gene is SQSTM1, which is mutated in about 10% of patients. Here we investigated the relationship between SQSTM1 mutation status, disease severity, and clinical outcome in 737 patients who took part in a randomized study of two different management strategies for the disease. Mutations of SQSTM1 were detected in 80 of 737 (10.9%) patients. Mutation carriers had an earlier age at diagnosis (59.4 Β±11.5 versus 65.0βΒ±β10.4 years, pβ<β.0001) and a greater number of affected bones (3.2βΒ±β1.2 versus 2.1βΒ±β1.2, pβ<β.001) and more commonly required orthopedic surgery (26.2% versus 16.1%, pβ=β.024) and bisphosphonate therapy (86.3% versus 75.2%, pβ=β.01) than those without mutations. Quality of life, as assessed by the shortβformβ36 (SF36) physical summary score, was significantly reduced in carriers (34.0βΒ±β11.3 versus 37.1βΒ±β11.4, pβ=β.036). During the study, fractures were more common in carriers (12.5% versus 5.3%, pβ=β.011), although most of these occurred in unaffected bone. This study demonstrates that SQSTM1 mutations are strongly associated with disease severity and complications of PDB. Genetic testing for SQSTM1 mutations may be of value in identifying individuals at risk of developing severe disease, but further studies will be required to determine if a program of genetic testing and early intervention in these individuals would be costβeffective or be of benefit in preventing these complications. Β© 2010 American Society for Bone and Mineral Research.
π SIMILAR VOLUMES
## Abstract ## Objective To estimate the occurrence of familial Paget's disease of bone in The Netherlands, to examine the prevalence of mutations of the sequestosome 1 gene (__SQSTM1__) in identified families, and to assess potential genotypeβphenotype associations. ## Methods We performed a ca
ABD mutations demonstrated that with only one exception disease-associated substitutions, surrounding hinge 1 demonstrated no tendency to form actin-filamin foci. The exception, a substitution in filamin repeat 6, lies within a region previously implicated in filamin-actin binding. These data are co
## Abstract Few reports have detailed mutation frequencies and mutation patterns in the entire X region according to clinical status. The aims of this study were to elucidate the relationships between mutation patterns and their frequencies in the X region and clinical status in a Korean cohort and
Communicated by